4502:TYO
Takeda Pharmaceutical Co Ltd
5Â 780,00Â JPÂ¥
arrow_upward
+0,71%(+41,00) 1D
30 sht, 3:30:00 m.d., GMT+9 · JPY
search
Të gjitha simbolet
1D
5D
1M
6M
YTD
1V
5V
Maks
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për 4502...
Hap
5Â 766Â JPÂ¥
I lartë
5Â 801Â JPÂ¥
I ulët
5Â 676Â JPÂ¥
Kapitalizimi i tregut
9,26Â bln
Vëllimi mesatar
4,17Â mln
Vëllimi
5,24Â mln
Dividendi
3,46%
Dividendi tremujor
50Â JPÂ¥
Data e ndërprerjes së dividendit
29 sht 2026
Maksimumi 52-javor
6Â 033Â JPÂ¥
Minimumi 52-javor
4Â 102Â JPÂ¥
Fitimet për aksion
-103Â JPÂ¥
Aksionet në qarkullim
784,48Â mln
Numri i punonjësve
47 mijë
Hap
5Â 766Â JPÂ¥
I lartë
5Â 801Â JPÂ¥
I ulët
5Â 676Â JPÂ¥
Kapitalizimi i tregut
9,26Â bln
Vëllimi mesatar
4,17Â mln
Vëllimi
5,24Â mln
Dividendi
3,46%
Dividendi tremujor
50Â JPÂ¥
Data e ndërprerjes së dividendit
29 sht 2026
Maksimumi 52-javor
6Â 033Â JPÂ¥
Minimumi 52-javor
4Â 102Â JPÂ¥
Fitimet për aksion
-103Â JPÂ¥
Aksionet në qarkullim
784,48Â mln
Numri i punonjësve
47 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Investing.com Canada
·
23 orë më parë
Keros Therapeutics to receive $20M milestone from Takeda By Investing.com
AD HOC NEWS
·
1 ditë më parë
Takeda Pharmaceutical stock reports Q1 revenue of JPY 1.22 trillion
Profili
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Rreth Takeda Pharmaceutical Co Ltd
Drejtori ekzekutivChristophe Weber | Christophe Weber
Punonjësit47 mijë
Themeluar më12 qer 1781
Selia-
Sektori-
Uebsajtitakeda.com